What it is
Cathelicidin LL-37 is a antimicrobial peptide. chronic infection, biofilm, immune modulation falls into the immunomodulator class, where research covers T-cell activity, antimicrobial response, and chronic-infection recovery. Pepture treats Cathelicidin LL-37 purely as a tracking target, meaning the app records what you enter without making any clinical recommendation about whether the compound is right for you. That determination belongs with a licensed clinician who knows your full history.
Most research and practitioner use reports subcutaneous (SubQ) injection with a U-100 insulin syringe. Its half-life of about 30 hours places it in the once-daily to every-other-day dosing window reported in the literature.
The Pepture library entry for Cathelicidin LL-37 exists so that if you are already logging a Cathelicidin LL-37 protocol, you can do so with structured fields, cycle calendars, injection-site rotation, and biomarker context rather than a loose notebook. If you are considering starting a protocol with Cathelicidin LL-37, speak with a licensed clinician before obtaining or dosing the compound.
Common uses
The uses most commonly logged for Cathelicidin LL-37 in the Pepture community align with its immune positioning. Users track Cathelicidin LL-37 alongside symptom log, CBC and CRP when available, and sleep quality, so the protocol's impact can be evaluated over a full cycle rather than by memory.
Typical logged doses in Pepture sit in the 100 mcg to 500 mcg range; individual protocols vary substantially.
Pepture makes no claim about efficacy. Cathelicidin LL-37 is either FDA-approved, used under a prescription, or labelled for research only depending on the jurisdiction. Confirm the legal and clinical status of Cathelicidin LL-37 in your country with a licensed clinician before use.
Reconstitution math
Open the pre-filled Cathelicidin LL-37 reconstitution calculator to compute syringe units per dose.
Reconstitution guidance
Typical vial size 5 mg. Reconstitute with 2 mL bacteriostatic water. Refrigerate after reconstitution per manufacturer or clinician guidance. Standard storage window: 28d refrigerated.
Stack combinations
Usually standalone within an immune-focused stack.
Cycle length norms
Tracked users commonly run 30 on / 14 off. Cycle norms vary by individual and by clinician guidance. Pepture lets you configure any on/off window that matches your protocol.
Safety considerations
Every peptide carries context-specific risks. Work with a licensed clinician who knows your medical history before starting or adjusting a protocol. Stop and seek medical attention for severe injection site reactions, unexpected swelling, shortness of breath, persistent elevated heart rate, rash, or any reaction you did not anticipate. Pepture does not assess efficacy or safety for any individual.
Reported Side Effects of Cathelicidin LL-37
Effects below are summarised from peer-reviewed literature or regulatory labeling where it exists. Not medical advice. Individual responses vary.
Used in these Pepture routines
CATHELICIDIN-LL-37 appears in the following Pepture stack templates. Tap to load the full routine.
Compare Cathelicidin LL-37
How Cathelicidin LL-37 stacks up against the peers most users consider.
References
For peer-reviewed literature, search PubMed for Cathelicidin LL-37. Pepture does not link to vendor or retail sites.
Disclaimer
The information on this page is for informational purposes only and is not medical, legal, or regulatory advice. Pepture does not sell, supply, prescribe, or recommend any peptide. Many peptides are investigational or restricted in specific jurisdictions.